Compare iShares 7-10 Year Treasury Bond ETF (IEF) vs Inovio Pharmaceuticals Inc (INO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
iShares 7-10 Year Treasury Bond ETF vs Inovio Pharmaceuticals Inc — how do they compare? iShares 7-10 Year Treasury Bond ETF trades at $93.32, while Inovio Pharmaceuticals Inc trades at $1.08 (market cap $89.27M). Which is the better fit depends on your goals.
| IEF | INO | |
|---|---|---|
52-Week High | $97.99 | $2.87 |
52-Week Low | $93.11 | $1.05 |
Market Cap | — | $89.27M |
Sector | — | Health |
Enterprise Value | — | $60.28M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About iShares 7-10 Year Treasury Bond ETF
The underlying index measures the performance of public obligations of the US Treasury that have a remaining maturity of greater than or equal to seven years and less than ten years. The fund will invest at least 80% of its assets in the component securities of the underlying index, and the fund will invest at least 90% of its assets in US Treasury securities that the advisor believes will help the fund track the underlying index.
Read more on IEF →About Inovio Pharmaceuticals Inc
Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Read more on INO →
